Newsroom | 1669 results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the fourth quarter and full year ended December 31, 2025. “Over the past twelve months, Biote has focused on our strategic priorities which are designed to drive sustainable profitable growth and create long-term value for stockholders,” said Bret Christensen, Biote’s Chief...

LOS ANGELES--(BUSINESS WIRE)--Herbalife, a premier health and wellness company, community and platform, today announced that it has renewed its support of the LA Galaxy Special Olympics Unified Team for the 2026 season. This partnership will offer Special Olympics athletes—ages 16 to 25— access to the same high-quality resources as the professional team including world-class nutrition education, elite training, and exclusive experiences, such as access to professional team gear, travel, scrimma...

LOS ANGELES--(BUSINESS WIRE)--Navigating Sex in Perimenopause: Expert Advice to Help Women Reclaim Confidence and Intimacy...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the “Selling Shareholders”) laun...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche EUR 500 million Eurobond. The bond has a 5-year maturity and carries a fixed-rate annual coupon of 3.375%. The Eurobond was placed on March 10, 2026,...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODi) (“BODi” or the “Company”), a leading fitness and nutrition company, today announced financial results for its fourth quarter ended December 31, 2025. “Over the past two years, we have taken bold steps to completely transform our company and our 4th quarter results are indicative of our successful efforts,” said Carl Daikleler, co-founder and BODi’s Chief Executive Officer. “Looking ahead, our strengthened financial...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Niagen® Skincare Innovation Lab, a new product innovation platform designed to translate the Company’s leadership in NAD+ science into category-defining skincare. Debuting under the platform is Niagen NanoCloud™, a limited-release, dermatologist-tested topical skincare product powered by...

WARREN, N.J.--(BUSINESS WIRE)--A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers. The findings come from an analysis of data from a randomized clinical trial, the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), designed to evaluate how daily multivitamin use may influence biological aging over time. Biological aging refers to how well the body is functioning at a cellular level and may add important information about health...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is launching its new Cetaphil AM/PM Antioxidant Serums, a breakthrough daily system clinically designed to defend skin by day and support accelerated repair by night for sensitive, stressed skin. While antioxidant serums are a cornerstone of modern skincare, the category has largely been developed without sensitive skin in mind. Despite r...

DALLAS, NEW YORK, LONDRA e TOKYO--(BUSINESS WIRE)--Lone Star Funds (“Lone Star”) oggi ha annunciato che un'affiliata di Lone Star Fund XII, L.P. ha firmato un accordo definitivo di acquisizione della divisione Capsules & Health Ingredients (“CHI”) di Lonza Group AG. Secondo i termini della transazione, Lonza tratterrà una partecipazione azionaria del 40% nell'azienda. Con sede a Basilea, Svizzera, CHI opera a livello globale nelle Americhe, in Europa e nella regione dell'Asia Pacifico. L'az...